BackBiogen Overview

Biogen Total Assets

Biogen's total assets is $32B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$32.09B
↑ 13.26% YoYΔ $3.76B vs prior year quarter

Peer trimmed avg / median

Loading

Biogen Total Assets History

Loading

Biogen vs. peers: Total Assets Comparison

Loading

Biogen Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biogen (BIIB) FAQ

As of the most recent data (June 2026), BIIB shows a total assets of $32B. That compares with $28B in the prior-year period — up 13.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIIB's total assets is now $32B (was $28B) — a 13.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biogen is outperforming or lagging.

Tracking BIIB's total assets over time shows whether Biogen is scaling, shrinking, or reshaping that part of the business. The current reading is $32B That compares with $28B in the prior-year period — up 13.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Biogen's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $32B) with ownership activity and broader fundamentals.

Biogen's total assets is $32B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.